 | • レポートコード：QYR9ST04854 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、痛風治療薬の世界市場について調査・分析し、痛風治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（NSAID、コルチコステロイド、コルヒチン、尿酸低下薬）、用途別（急性痛風、慢性痛風）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の痛風治療薬市場動向 ・主要企業別マーケットシェア ・痛風治療薬の種類別市場規模2014-2019 （NSAID、コルチコステロイド、コルヒチン、尿酸低下薬） ・痛風治療薬の用途別市場規模2014-2019 （急性痛風、慢性痛風） ・痛風治療薬の北米市場：主要企業・種類別/用途別市場規模 ・痛風治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・痛風治療薬の中国市場：主要企業・種類別/用途別市場規模 ・痛風治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・痛風治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・痛風治療薬のインド市場：主要企業・種類別/用途別市場規模 ・痛風治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Takeda Pharmaceutical Company、Novartis、AstraZeneca、GlaxoSmithKline、Merck、Regeneron Pharmaceuticals） ・痛風治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries.Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction. Technological advancements in medical imaging is another factor augmenting the demand in the gout therapeutics market. On the other hand, low levels of physician and patient awareness, heavy dependency on generic drugs, and use of CAM for the treatment of gout are restraining factors over the global gout therapeutics market.
At present, the Americas is the largest market for gout therapeutics and is estimated to retain its hold over the market until the end of 2020. The market in this region is growing briskly due to the higher incidences of gout in the US, which results in the growing consumption of gout drugs. In this region, novel therapies like llaris and lesinurad FDC are expected to launch during the forecast period in the US as they have proven benefits over the standard of care. This indicates that novel therapies will have a favorable market potential and good market success during the forecast period.
In 2018, the global Gout Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Gout Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gout Therapeutics development in United States, Europe and China.
The key players covered in this study
Takeda Pharmaceutical Company
Novartis
AstraZeneca
GlaxoSmithKline
Merck
Regeneron Pharmaceuticals
…
Market segment by Type, the product can be split into
NSAIDs
Corticosteroids
Colchicine
Urate-Lowering Agents
Market segment by Application, split into
Acute Gout
Chronic Gout
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Gout Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Gout Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Gout Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gout Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 NSAIDs
1.4.3 Corticosteroids
1.4.4 Colchicine
1.4.5 Urate-Lowering Agents
1.5 Market by Application
1.5.1 Global Gout Therapeutics Market Share by Application (2014-2025)
1.5.2 Acute Gout
1.5.3 Chronic Gout
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gout Therapeutics Market Size
2.2 Gout Therapeutics Growth Trends by Regions
2.2.1 Gout Therapeutics Market Size by Regions (2014-2025)
2.2.2 Gout Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Gout Therapeutics Market Size by Manufacturers
3.1.1 Global Gout Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Gout Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gout Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gout Therapeutics Key Players Head office and Area Served
3.3 Key Players Gout Therapeutics Product/Solution/Service
3.4 Date of Enter into Gout Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gout Therapeutics Market Size by Type (2014-2019)
4.2 Global Gout Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Gout Therapeutics Market Size (2014-2019)
5.2 Gout Therapeutics Key Players in United States
5.3 United States Gout Therapeutics Market Size by Type
5.4 United States Gout Therapeutics Market Size by Application
6 Europe
6.1 Europe Gout Therapeutics Market Size (2014-2019)
6.2 Gout Therapeutics Key Players in Europe
6.3 Europe Gout Therapeutics Market Size by Type
6.4 Europe Gout Therapeutics Market Size by Application
7 China
7.1 China Gout Therapeutics Market Size (2014-2019)
7.2 Gout Therapeutics Key Players in China
7.3 China Gout Therapeutics Market Size by Type
7.4 China Gout Therapeutics Market Size by Application
8 Japan
8.1 Japan Gout Therapeutics Market Size (2014-2019)
8.2 Gout Therapeutics Key Players in Japan
8.3 Japan Gout Therapeutics Market Size by Type
8.4 Japan Gout Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gout Therapeutics Market Size (2014-2019)
9.2 Gout Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Gout Therapeutics Market Size by Type
9.4 Southeast Asia Gout Therapeutics Market Size by Application
10 India
10.1 India Gout Therapeutics Market Size (2014-2019)
10.2 Gout Therapeutics Key Players in India
10.3 India Gout Therapeutics Market Size by Type
10.4 India Gout Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Gout Therapeutics Market Size (2014-2019)
11.2 Gout Therapeutics Key Players in Central & South America
11.3 Central & South America Gout Therapeutics Market Size by Type
11.4 Central & South America Gout Therapeutics Market Size by Application
12 International Players Profiles
12.1 Takeda Pharmaceutical Company
12.1.1 Takeda Pharmaceutical Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gout Therapeutics Introduction
12.1.4 Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2014-2019)
12.1.5 Takeda Pharmaceutical Company Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gout Therapeutics Introduction
12.2.4 Novartis Revenue in Gout Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gout Therapeutics Introduction
12.3.4 AstraZeneca Revenue in Gout Therapeutics Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gout Therapeutics Introduction
12.4.4 GlaxoSmithKline Revenue in Gout Therapeutics Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gout Therapeutics Introduction
12.5.4 Merck Revenue in Gout Therapeutics Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Regeneron Pharmaceuticals
12.6.1 Regeneron Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gout Therapeutics Introduction
12.6.4 Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2014-2019)
12.6.5 Regeneron Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Gout Therapeutics Key Market Segments
Table Key Players Gout Therapeutics Covered
Table Global Gout Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gout Therapeutics Market Size Market Share by Type 2014-2025
Figure NSAIDs Figures
Table Key Players of NSAIDs
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Figure Colchicine Figures
Table Key Players of Colchicine
Figure Urate-Lowering Agents Figures
Table Key Players of Urate-Lowering Agents
Table Global Gout Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Acute Gout Case Studies
Figure Chronic Gout Case Studies
Figure Gout Therapeutics Report Years Considered
Table Global Gout Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Gout Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gout Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Gout Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Gout Therapeutics Market Share by Regions 2014-2019
Figure Global Gout Therapeutics Market Share by Regions 2014-2019
Figure Global Gout Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Gout Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gout Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Gout Therapeutics Market Share by Manufacturers in 2018
Table Global Gout Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gout Therapeutics Product/Solution/Service
Table Date of Enter into Gout Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gout Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Gout Therapeutics Market Size Share by Type (2014-2019)
Figure Global Gout Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Gout Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Gout Therapeutics Market Size Share by Application (2014-2019)
Figure Global Gout Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Gout Therapeutics Revenue Market Share by Application in 2018
Figure United States Gout Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Gout Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Gout Therapeutics Market Share (2018-2019)
Table United States Gout Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Gout Therapeutics Market Share by Type (2014-2019)
Table United States Gout Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Gout Therapeutics Market Share by Application (2014-2019)
Figure Europe Gout Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Gout Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Gout Therapeutics Market Share (2018-2019)
Table Europe Gout Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Gout Therapeutics Market Share by Type (2014-2019)
Table Europe Gout Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Gout Therapeutics Market Share by Application (2014-2019)
Figure China Gout Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Gout Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Gout Therapeutics Market Share (2018-2019)
Table China Gout Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Gout Therapeutics Market Share by Type (2014-2019)
Table China Gout Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Gout Therapeutics Market Share by Application (2014-2019)
Figure Japan Gout Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Gout Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Gout Therapeutics Market Share (2018-2019)
Table Japan Gout Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Gout Therapeutics Market Share by Type (2014-2019)
Table Japan Gout Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Gout Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Gout Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gout Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gout Therapeutics Market Share (2018-2019)
Table Southeast Asia Gout Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gout Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Gout Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gout Therapeutics Market Share by Application (2014-2019)
Figure India Gout Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Gout Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Gout Therapeutics Market Share (2018-2019)
Table India Gout Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Gout Therapeutics Market Share by Type (2014-2019)
Table India Gout Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Gout Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Gout Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gout Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gout Therapeutics Market Share (2018-2019)
Table Central & South America Gout Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gout Therapeutics Market Share by Type (2014-2019)
Table Central & South America Gout Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gout Therapeutics Market Share by Application (2014-2019)
Table Takeda Pharmaceutical Company Company Details
Table Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2014-2019) (Million US$)
Figure Takeda Pharmaceutical Company Revenue Growth Rate in Gout Therapeutics Business (2014-2019)
Table Takeda Pharmaceutical Company Recent Development
Table Novartis Company Details
Table Novartis Revenue in Gout Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Gout Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Gout Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Gout Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Gout Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Gout Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Gout Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Gout Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Gout Therapeutics Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Global Gout Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Gout Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Gout Therapeutics Market Size Share by Regions in 2025
Figure United States Gout Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gout Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Gout Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gout Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gout Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Gout Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gout Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Gout Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Gout Therapeutics Market Size by Product (2019-2025)
Figure Global Gout Therapeutics Market Size by Product in 2025
Table Global Gout Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Gout Therapeutics Market Size by Application (2019-2025)
Figure Global Gout Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
痛風病治療の世界市場：市場規模・現状・予測 Gout is a disease characterized by recurrent attacks of acute inflammatory arthritis.The increase in the number of gout disease incidences and strong development of the treatment are some of the major factors driving the global gout disease treatment market. Improvised study on gout therapeutics and…- 急性腎不全治療薬の世界市場：市場規模・現状・予測 Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body.Acute ren…
- 急性骨髄性白血病（AML）治療薬の世界市場：市場規模・現状・予測 In 2018, the global Acute Myeloid Leukemia (AML) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Acute Myeloid Leukemia (AML) Therapeutics status, future forecast, growth…
- 急性骨髄性白血病（AML）治療薬の世界市場：市場規模・現状・予測 Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90…
- ホジキンリンパ腫治療の世界市場：市場規模・現状・予測 Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…